Access cutting-edge multiple sclerosis treatment through this clinical trial at a research site in Waltham. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Waltham location
Preparing your pre-screening questions…
Access multiple sclerosis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple sclerosis treatment provided free
Check if you qualify for this multiple sclerosis clinical trial in Waltham, MA
No-Cost Study Care
Local to Waltham
Convenient for MA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
CAFE-MS will assess the effectiveness of two online programs for fatigue in multiple sclerosis (MS). Although they differ, both of these online programs contain information about MS and fatigue intended to help people with MS understand and manage their fatigue. This large-scale, decentralized clinical trial is projected to enroll 2,000 people with MS. The collaboration between iConquerMS and 5 Veterans Affairs (VA) sites in the MS Centers of Excellence is designed to ensure sufficient representation of people with MS from populations traditionally under-represented in MS clinical trials. The study is a 3-arm, randomized controlled clinical trial with study participation lasting 1 year. Two of the trial arms will include one of two online programs for managing fatigue in MS added to the trial participants' usual MS treatment, and the third arm will include usual MS treatment alone. The online program phase of the trial lasts for 6 months after randomization followed by a final study visit at 12 months. Participants in the usual MS treatment alone arm for the first 6 months will have an opportunity to choose one of the online programs for the final 6 months of the trial.
Sponsor: Accelerated Cure Project for Multiple Sclerosis
Yes, this clinical trial (NCT06441617) has an active research site in Waltham, MA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for multiple sclerosis treatment options in Waltham, MA, this clinical trial (NCT06441617) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Waltham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all multiple sclerosis clinical trials near you to find additional studies recruiting in your area.
See all multiple sclerosis clinical trials recruiting in Waltham — not just this study.
Browse Multiple Sclerosis Trials in Waltham →